TAROS Tablets (Talinopram)

Adult dose

Administer talniflumate 370 mg orally per dose 3 times a day. In severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This medication should be consulted with a doctor or pharmacist if taken by individuals who regularly consume more than three drinks a day, as it may cause gastrointestinal bleeding. This medication may affect the cardiovascular system, increasing the risk of serious cardiovascular diseases such as myocardial infarction or stroke; therefore, individuals with cardiovascular diseases or risk factors should be particularly cautious. It can also impact the gastrointestinal tract, leading to serious issues such as bleeding, ulcers, or perforations in the stomach or intestines, thus elderly individuals or those with a history of gastrointestinal diseases should take it with caution. Individuals with a history of peptic ulcers, allergies to this medication's components, past allergic reactions to aspirin, severe liver, kidney, or heart disease, and women who are pregnant or breastfeeding should not take this medication. Occasionally, gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, skin rashes, itching, and rarely severe skin reactions may occur, so if unusual symptoms develop, immediately consult healthcare personnel. This medication may raise blood pressure or worsen symptoms of heart failure, so individuals with high blood pressure or heart disease should carefully monitor their blood pressure and symptoms while taking it. If this medication is taken for an extended period, regular monitoring of liver function, kidney function, and blood tests should be conducted, and if abnormalities are detected, discontinuation may be necessary. This medication may interact with other anti-inflammatory analgesics, anticoagulants, diuretics, lithium, methotrexate, etc., so if other medications are being taken, it is essential to inform healthcare personnel. During pregnancy, particularly in the late stages, it may pose risks to the fetus, so it should not be taken; and for breastfeeding women, safety has not been established, so consideration should be given to discontinuing breastfeeding or the medication. Use in children, especially those under 12 years of age, is not recommended, and elderly individuals should take the minimum dosage with caution. Finally, this medication should be stored out of reach of children and should not be transferred to another container.

• Nausea
• vomiting
• photosensitivity
• asthma attacks
• systemic weakness due to hypotension
• hypersensitivity shock
• diarrhea
• abdominal distension
• constipation
• dyspepsia

This medication should be stored in a tightly closed container to prevent air from entering and kept at room temperature, avoiding extremes of heat or cold. Storing it this way will help maintain its effectiveness for a long time.

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle